Rob is a diversely trained principal scientist with over 15 years of experience developing and advancing a wide array of preclinical programs.  As Chief Technology Officer, Rob leads the design and implementation of Virscio’s research platforms and manages IT, research, data management and operations teams.  Rob directs Virscio’s U.S. facility in New Haven, CT.  Rob received his Ph.D. in Pharmacology from the University of Surrey, England and completed postdoctoral appointments in neurobiology and neurovirology at the University of Kentucky and University of Colorado Health Sciences Center, respectively.  Rob also brings direct pharmaceutical industry experience in pharmacology and drug metabolism and extensive experience in neuroscience, ophthalmology, virology and immunology.  Rob additionally plays a key role in developing and advancing Virscio’s preclinical service strategy and implementation of associated technologies.